PAVmed targets Varis FDA submission by end of 2026 while evaluating new assets following cap table cleanup (NASDAQ:PAVM)
PAVmed(US:PAVM) Seeking Alpha·2026-05-15 23:42To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...